Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270670 · ClinicalTrials.gov registry record
Olympus - 19-gauge Needle
A clinical trial of Lung Cancer, sponsored by Duke University.
- Completed
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT03270670 is a study of Lung Cancer that has completed, run by Duke University. The registered enrollment target is 50 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03270670, a study of Lung Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test whether the 19-gauge needle can collect more tissue and get better sampling during a bronchoscopy procedure.
Conditions Studied
Study Locations (2)
Missouri
- Washington University in St. Louis - St Louis
North Carolina
- Duke Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2019-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03270670
The ClinicalTrials.gov registry entry for NCT03270670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03270670 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03270670 about?
NCT03270670 is a clinical study titled "Olympus - 19-gauge Needle". The purpose of this study is to test whether the 19-gauge needle can collect more tissue and get better sampling during a bronchoscopy procedure.
What is the current status of trial NCT03270670?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-08-21. Estimated completion is 2019-01-30.
What conditions does trial NCT03270670 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT03270670?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03270670 being conducted?
This trial has 2 study locations across Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.